1. Home
  2. IHT vs IMNN Comparison

IHT vs IMNN Comparison

Compare IHT & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InnSuites Hospitality Trust Shares of Beneficial Interest

IHT

InnSuites Hospitality Trust Shares of Beneficial Interest

N/A

Current Price

$1.34

Market Cap

15.2M

Sector

Finance

ML Signal

N/A

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$1.47

Market Cap

9.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IHT
IMNN
Founded
1971
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.2M
9.1M
IPO Year
1995
2000

Fundamental Metrics

Financial Performance
Metric
IHT
IMNN
Price
$1.34
$1.47
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
21.9K
43.0K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
1.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,600,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.33
N/A
52 Week Low
$0.95
$1.47
52 Week High
$4.24
$5.85

Technical Indicators

Market Signals
Indicator
IHT
IMNN
Relative Strength Index (RSI) 39.81 35.49
Support Level $1.23 N/A
Resistance Level $1.51 $2.18
Average True Range (ATR) 0.10 0.10
MACD 0.00 -0.01
Stochastic Oscillator 37.18 26.03

Price Performance

Historical Comparison
IHT
IMNN

About IHT InnSuites Hospitality Trust Shares of Beneficial Interest

InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns interests in two hotels, operates and provides management services, and provides trademark license services, for two hotels. The Trust also holds an investment related to clean energy electricity generation technology and manages an option to acquire an investment in an independent boutique hotel reservation and hotel services business.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

Share on Social Networks: